Disclosed positions

Estimated from their latest filings — positions may have changed since

$848.2K

combined est. value

Stock	Shares	Price	Value	Weight	As of
ARQTArcutis Biotherapeutics, Inc.	27,567	$25.89	$713.7K	84%	2026-06-15
STVNStevanato Group S.p.A.	6,975	$19.28	$134.5K	16%	2026-06-12

ARQT

Arcutis Biotherapeutics, Inc.

$713.7K

27,567 sh

STVN

Stevanato Group S.p.A.

$134.5K

6,975 sh

All filings on record

Every Form 4 transaction we track for this filer

all 7buys 0sells 2

Stock	Transaction	Date	~6mo later
ARQTArcutis Biotherapeutics, Inc.	Sell $120.6K · 4,946 sh	2026-06-15	—
STVNStevanato Group S.p.A.	Grant — · 4,975 sh	2026-06-12	—
ARQTArcutis Biotherapeutics, Inc.	Grant — · 5,778 sh	2026-06-05	—
ARQTArcutis Biotherapeutics, Inc.	Sell $778.0K · 25,272 sh	2025-11-24	—
ARQTArcutis Biotherapeutics, Inc.	Exercise $54.2K · 7,220 sh	2025-11-24	—
ARQTArcutis Biotherapeutics, Inc.	Exercise $155.8K · 18,052 sh	2025-11-24	—
ARQTArcutis Biotherapeutics, Inc.	Grant — · 7,609 sh	2025-06-12	—

ARQTSell

2026-06-15 · Arcutis Biotherapeutics, Inc.

$120.6K

—

STVNGrant

2026-06-12 · Stevanato Group S.p.A.

4,975

—

ARQTGrant

2026-06-05 · Arcutis Biotherapeutics, Inc.

5,778

—

ARQTSell

2025-11-24 · Arcutis Biotherapeutics, Inc.

$778.0K

—

ARQTExercise

2025-11-24 · Arcutis Biotherapeutics, Inc.

$54.2K

—

ARQTExercise

2025-11-24 · Arcutis Biotherapeutics, Inc.

$155.8K

—

ARQTGrant

2025-06-12 · Arcutis Biotherapeutics, Inc.

7,609

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.